PTGX — Protagonist Therapeutics Share News
0.000.00%
Last trade - 00:00- $8.84bn
- $8.05bn
- $46.02m
U.S. STOCKS ON THE MOVE-MP Materials, Five9, Alphabet
U.S. STOCKS ON THE MOVE-MercadoLibre, CrowdStrike Holdings, Protagonist Therapeutics
Protagonist Therapeutics rises on quarterly profit beat
U.S. RESEARCH ROUNDUP- CPI Card Group, First Solar, Viking Therapeutics
Protagonist Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
U.S. RESEARCH ROUNDUP-Cigna, Marriott, Ralph Lauren
Protagonist Therapeutics Inc expected to post a loss of 62 cents a share - Earnings Preview
Protagonist Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Protagonist Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Protagonist Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
Protagonist Therapeutics Inc expected to post a loss of 60 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Edwards Lifesciences, National Bank Holdings, Sage Therapeutics
U.S. RESEARCH ROUNDUP-Alphabet, GE Aerospace, Tesla
U.S. STOCKS ON THE MOVE-Infinera, Landbridge, Tempus AI
U.S. STOCKS ON THE MOVE-ARS Pharma, Digital Realty, Capricor Therapeutics
U.S. STOCKS ON THE MOVE-Protagonist Therapeutics, Infinera, GEO Group
Protagonist Therapeutics jumps on S&P SmallCap addition
U.S. RESEARCH ROUNDUP-Biontech, Honeywell International, Klaviyo
Protagonist Therapeutics Inc reports results for the quarter ended in March - Earnings Summary